These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7404345)
1. [Indicators of trioxipurine metabolism in healthy persons and in patients with acute diffuse glomerulonephritis]. Eĭl'bart VL Ter Arkh; 1980; 52(4):73-5. PubMed ID: 7404345 [No Abstract] [Full Text] [Related]
2. [Evaluation of urate homeostasis in chronic glomerulonephritis]. Burian AE Klin Med (Mosk); 1980 Jul; 58(7):100-4. PubMed ID: 7289451 [No Abstract] [Full Text] [Related]
3. [State of lipid metabolism in acute and chronic diffuse glomerulonephritis]. Alekseev GI; Storozhenko AA Klin Med (Mosk); 1974 Jan; 52(1):70-4. PubMed ID: 4466890 [No Abstract] [Full Text] [Related]
4. [Uric acid metabolism abnormalities in IgA nephropathies]. Konopielko Z; Zawadzki J; Wyszyńska T Pediatr Pol; 1996 Apr; 71(4):327-30. PubMed ID: 8975220 [TBL] [Abstract][Full Text] [Related]
5. Tophaceous gout in young patients with systemic lupus erythematosus. Veerapen K; Schumacher HR; van Linthoudt D; Neilson EG; Wang F J Rheumatol; 1993 Apr; 20(4):721-4. PubMed ID: 8496872 [TBL] [Abstract][Full Text] [Related]
7. [Group study on enzymes in kidney diseases with particular consideration on the activity of the blood serum and urine. II. Acute diffuse glomerulonephritis]. BARABAN H Pol Arch Med Wewn; 1961; 31():1337-47. PubMed ID: 13864729 [No Abstract] [Full Text] [Related]
8. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. Urano W; Yamanaka H; Tsutani H; Nakajima H; Matsuda Y; Taniguchi A; Hara M; Kamatani N J Rheumatol; 2002 Sep; 29(9):1950-3. PubMed ID: 12233891 [TBL] [Abstract][Full Text] [Related]
9. Uric acid administration for neuroprotection in patients with acute brain ischemia. Chamorro A; Planas AM; Muner DS; Deulofeu R Med Hypotheses; 2004; 62(2):173-6. PubMed ID: 14962621 [TBL] [Abstract][Full Text] [Related]
10. [Serotonin in the course of acute glomerulonephritis in children]. Szajner-Milart I Pediatr Pol; 1980 Jun; 55(6):729-38. PubMed ID: 7413322 [No Abstract] [Full Text] [Related]
11. [Uric acid as a scavenger in oxidative stress]. Staub M Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505 [TBL] [Abstract][Full Text] [Related]
12. Potential role of uric acid in the molecular pathogenesis of age-related macular degeneration. Mehryar M; Farvardin M; Hosseini H; Aslani M Med Hypotheses; 2006; 66(4):793-5. PubMed ID: 16326027 [TBL] [Abstract][Full Text] [Related]
13. [Acute urate nephropathy in perimenopausal women]. Solov'eva OA; Balkarov IM; Miroshnichenko NG; Kireeva VI Ter Arkh; 2006; 78(10):61-4. PubMed ID: 17180941 [No Abstract] [Full Text] [Related]
14. [Vasoactive factors in chronic glomerulonephritis]. Knotková V; Havrda M; Jáchymová M; Jindra V Cas Lek Cesk; 1996 Nov; 135(21):687-90. PubMed ID: 8998817 [TBL] [Abstract][Full Text] [Related]
16. Uric acid: role in cardiovascular disease and effects of losartan. Alderman M; Aiyer KJ Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846 [TBL] [Abstract][Full Text] [Related]
17. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382 [TBL] [Abstract][Full Text] [Related]
18. AT1 blockers and uric acid metabolism: are there relevant differences? Puig JG; Torres R; Ruilope LM J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060 [TBL] [Abstract][Full Text] [Related]
20. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis. Paydas S; Balal M; Tanriverdi K; Sertdemir Y; Baslamisli F Ren Fail; 2007; 29(7):779-84. PubMed ID: 17994443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]